EMEA-002812-PIP02-20-M01
Key facts
| Invented name |
Vydura
|
| Active substance |
Rimegepant
|
| Therapeutic area |
Neurology
|
| Decision number |
P/0299/2022
|
| PIP number |
EMEA-002812-PIP02-20-M01
|
| Pharmaceutical form(s) |
Oral lyophilisate
|
| Condition(s) / indication(s) |
Treatment of migraine headaches
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Biohaven Pharmaceuticals, Inc.
E-mail: medinfo@biohavenpharma.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|